In Vivo Sol-Gel Reaction of Tantalum Alkoxide for Endovascular Embolization
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, Giho | - |
dc.contributor.author | Choi, Jin Woo | - |
dc.contributor.author | Shin, Kwangsoo | - |
dc.contributor.author | Kim, Young Geon | - |
dc.contributor.author | Kang, Taegyu | - |
dc.contributor.author | Kim, Dokyoon | - |
dc.contributor.author | Lee, Nohyun | - |
dc.contributor.author | Kim, Hyo-Cheol | - |
dc.contributor.author | Hyeon, Taeghwan | - |
dc.date.accessioned | 2022-07-18T01:20:27Z | - |
dc.date.available | 2022-07-18T01:20:27Z | - |
dc.date.created | 2022-05-18 | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 2192-2640 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/107989 | - |
dc.description.abstract | Liquid embolic agents are considered the most promising for various embolization procedures because they enable deep penetration. For realizing effective procedures, the delivery of liquid embolic agents should be guided under X-ray imaging systems and the solidification time should be optimized for the specific indication. The biocompatibility of embolic agents is also crucial because they remain in the vessel after embolization. In this study, new biocompatible embolic agents based on tantalum ethoxide is synthesized. Tantalum alkoxide liquid embolics (TALE) possess the radiopacity for fluoroscopy and can control the penetration depth by modifying the sol-gel kinetics. Furthermore, TALE can serve as drug carriers for synergistic treatment. Using these excellent characteristics, it is demonstrated that TALE agents can be used in various situations including the transarterial chemoembolization of hepatocellular carcinoma and embolotherapy of massive bleeding from the femoral artery. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | In Vivo Sol-Gel Reaction of Tantalum Alkoxide for Endovascular Embolization | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Dokyoon | - |
dc.identifier.doi | 10.1002/adhm.202101908 | - |
dc.identifier.scopusid | 2-s2.0-85119661240 | - |
dc.identifier.wosid | 000722264300001 | - |
dc.identifier.bibliographicCitation | ADVANCED HEALTHCARE MATERIALS, v.11, no.4, pp.1 - 10 | - |
dc.relation.isPartOf | ADVANCED HEALTHCARE MATERIALS | - |
dc.citation.title | ADVANCED HEALTHCARE MATERIALS | - |
dc.citation.volume | 11 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Early Access | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | OXIDE NANOPARTICLES | - |
dc.subject.keywordPlus | CHEMOEMBOLIZATION | - |
dc.subject.keywordAuthor | cancer | - |
dc.subject.keywordAuthor | embolization | - |
dc.subject.keywordAuthor | HCC | - |
dc.subject.keywordAuthor | liquid embolic agents | - |
dc.subject.keywordAuthor | minimally invasive procedures | - |
dc.subject.keywordAuthor | sol-gel reaction | - |
dc.identifier.url | https://www.scopus.com/record/display.uri?eid=2-s2.0-85119661240&origin=inward&txGid=be65e5f4a6db313ed0ed77bf6d9dffbe | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.